Published in PLoS One on June 03, 2013
NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension. Br J Pharmacol (2014) 0.88
STIM1/ORAI1-mediated Ca2+ Influx Regulates Enolase-1 Exteriorization. J Biol Chem (2015) 0.79
Activated prostaglandin D2 receptors on macrophages enhance neutrophil recruitment into the lung. J Allergy Clin Immunol (2016) 0.77
Poly(I:C) Induces Human Lung Endothelial Barrier Dysfunction by Disrupting Tight Junction Expression of Claudin-5. PLoS One (2016) 0.75
A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem (1985) 90.20
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55
Requirement of the inositol trisphosphate receptor for activation of store-operated Ca2+ channels. Science (2000) 5.04
Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science (2008) 4.41
When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology (1996) 4.02
Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol (2004) 3.54
Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A (2007) 3.36
Ion channels and their functional role in vascular endothelium. Physiol Rev (2001) 3.26
Toll-like receptor signaling. J Biol Chem (2003) 3.24
TLR3 in antiviral immunity: key player or bystander? Trends Immunol (2005) 2.40
Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nat Genet (2009) 2.22
Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev Mol Med (2009) 2.12
Sustained Ca2+ transfer across mitochondria is Essential for mitochondrial Ca2+ buffering, sore-operated Ca2+ entry, and Ca2+ store refilling. J Biol Chem (2003) 1.71
Ca2+ signaling, TRP channels, and endothelial permeability. Microcirculation (2006) 1.70
IFN-alpha enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression. J Immunol (2005) 1.67
Ca(2+)-related signaling and protein phosphorylation abnormalities play central roles in a new experimental model of electrical storm. Circulation (2011) 1.58
Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems. Blood (2007) 1.57
Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice. Respir Res (2009) 1.29
The sarco/endoplasmic reticulum calcium-ATPase 2b is an endoplasmic reticulum stress-inducible protein. J Biol Chem (2000) 1.28
Protein kinase C modulates pulmonary endothelial permeability: a paradigm for acute lung injury. Am J Physiol Lung Cell Mol Physiol (2003) 1.26
A second binding site for double-stranded RNA in TLR3 and consequences for interferon activation. Nat Struct Mol Biol (2008) 1.24
Endothelial permeability is controlled by spatially defined cytoskeletal mechanics: atomic force microscopy force mapping of pulmonary endothelial monolayer. Nanomedicine (2008) 1.21
Store-operated calcium entry promotes shape change in pulmonary endothelial cells expressing Trp1. Am J Physiol (1998) 1.20
Double-stranded RNA exacerbates pulmonary allergic reaction through TLR3: implication of airway epithelium and dendritic cells. J Immunol (2010) 1.14
Functional role of TRPC channels in the regulation of endothelial permeability. Pflugers Arch (2005) 1.13
TLR3 activation stimulates cytokine secretion without altering agonist-induced human small airway contraction or relaxation. Am J Physiol Lung Cell Mol Physiol (2009) 1.08
Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor. Blood (2007) 1.07
Activation of endothelial toll-like receptor 3 impairs endothelial function. Circ Res (2011) 1.06
CXCR2/CXCR2 ligand biological axis impairs alveologenesis during dsRNA-induced lung inflammation in mice. Pediatr Res (2005) 1.01
Stiffness and heterogeneity of the pulmonary endothelial glycocalyx measured by atomic force microscopy. Am J Physiol Lung Cell Mol Physiol (2011) 0.99
Regulation of cerebral endothelial cell morphology by extracellular calcium. Phys Med Biol (2007) 0.98
Signaling mechanism of extracellular RNA in endothelial cells. FASEB J (2009) 0.98
Ca2+-pumps and Na2+-Ca2+-exchangers in coronary artery endothelium versus smooth muscle. J Cell Mol Med (2007) 0.96
Changes induced by hyperosmotic mannitol in cerebral endothelial cells: an atomic force microscopic study. Eur Biophys J (2006) 0.94
Modulation of double-stranded RNA-mediated gene induction by interferon in human umbilical vein endothelial cells. J Interferon Cytokine Res (2000) 0.94
Phosphatidylinositol 3-kinase regulates Ca2+ signaling in pancreatic acinar cells through inhibition of sarco(endo)plasmic reticulum Ca2+-ATPase. Am J Physiol Gastrointest Liver Physiol (2004) 0.93
Peripheral blood mononuclear cells increase the permeability of dengue virus-infected endothelial cells in association with downregulation of vascular endothelial cadherin. J Gen Virol (2008) 0.93
Double-stranded RNA induces similar pulmonary dysfunction to respiratory syncytial virus in BALB/c mice. Am J Physiol Lung Cell Mol Physiol (2011) 0.92
Ca2+ refilling of the endoplasmic reticulum is largely preserved albeit reduced Ca2+ entry in endothelial cells. Cell Calcium (2006) 0.92
Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1. Mol Cancer (2009) 0.90
Endothelium-derived prostaglandin I(2) controls the migration of eosinophils. J Allergy Clin Immunol (2010) 0.88
Phospholamban is present in endothelial cells and modulates endothelium-dependent relaxation. Evidence from phospholamban gene-ablated mice. Circ Res (1999) 0.88
A key role for Toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells. Blood (2008) 0.87
The exit from G(0) into the cell cycle requires and is controlled by sarco(endo)plasmic reticulum Ca2+ pump. Arch Biochem Biophys (1996) 0.86
Bluetongue virus and double-stranded RNA increase human vascular permeability: role of p38 MAPK. J Clin Immunol (2006) 0.85
SERCA pump isoform expression in endothelium of veins and arteries: every endothelium is not the same. Mol Cell Biochem (2000) 0.82
Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol (2009) 5.31
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet (2002) 4.63
Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol (2004) 3.63
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J (2004) 3.51
Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med (2004) 2.80
Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation (2006) 2.67
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. J Am Coll Cardiol (2010) 2.55
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat (2006) 2.30
Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nat Genet (2009) 2.22
Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries. Eur Respir J (2012) 2.16
Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med (2014) 2.14
Thrombin impairs alveolar fluid clearance by promoting endocytosis of Na+,K+-ATPase. Am J Respir Cell Mol Biol (2005) 1.91
Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange. Proc Natl Acad Sci U S A (2006) 1.89
Ambrisentan therapy for pulmonary arterial hypertension. J Am Coll Cardiol (2005) 1.82
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol (2009) 1.78
CD203c-based basophil activation test in allergy diagnosis: characteristics and differences to CD63 upregulation. Cytometry B Clin Cytom (2010) 1.75
Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med (2002) 1.72
Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med (2002) 1.72
Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy. Am J Respir Crit Care Med (2010) 1.69
Oleic acid inhibits alveolar fluid reabsorption: a role in acute respiratory distress syndrome? Am J Respir Crit Care Med (2004) 1.66
Assessment and prognostic relevance of right ventricular contractile reserve in patients with severe pulmonary hypertension. Circulation (2013) 1.62
Baseline and follow-up 6-min walk distance and brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension. Chest (2013) 1.58
Uremia alters HDL composition and function. J Am Soc Nephrol (2011) 1.55
Identification of indole derivatives exclusively interfering with a G protein-independent signaling pathway of the prostaglandin D2 receptor CRTH2. Mol Pharmacol (2005) 1.54
Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography vs right-sided heart catheterization. Chest (2010) 1.52
The emerging role of magnetic resonance imaging in the diagnosis and management of pulmonary hypertension. Respiration (2008) 1.51
Impact of TASK-1 in human pulmonary artery smooth muscle cells. Circ Res (2006) 1.44
Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension. J Am Coll Cardiol (2003) 1.43
In vitro models of the blood-brain barrier. Acta Neurobiol Exp (Wars) (2011) 1.43
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. J Am Coll Cardiol (2004) 1.42
Effect of inhaled iloprost during off-medication time in patients with pulmonary arterial hypertension. Respiration (2007) 1.42
Magnetic resonance-derived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure. Circ Cardiovasc Imaging (2008) 1.38
E-type prostanoid receptor 4 (EP4) in disease and therapy. Pharmacol Ther (2013) 1.28
Protein carbamylation renders high-density lipoprotein dysfunctional. Antioxid Redox Signal (2011) 1.27
CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases. Pharmacology (2010) 1.26
Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension. J Am Coll Cardiol (2009) 1.24
Inflammation alters HDL composition and function: implications for HDL-raising therapies. Pharmacol Ther (2012) 1.23
Proton transport by proteorhodopsin requires that the retinal Schiff base counterion Asp-97 be anionic. Biochemistry (2003) 1.23
Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol (2004) 1.22
Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med (2003) 1.22
GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils. Cell Res (2011) 1.21
Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med (2009) 1.21
Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol (2011) 1.16
Inhibition of autophagy rescues palmitic acid-induced necroptosis of endothelial cells. J Biol Chem (2012) 1.16
Expression and regulation of toll-like receptors in cerebral endothelial cells. Neurochem Int (2010) 1.14
Role of ion channels in acute and chronic responses of the pulmonary vasculature to hypoxia. Cardiovasc Res (2006) 1.14
Transmigration of melanoma cells through the blood-brain barrier: role of endothelial tight junctions and melanoma-released serine proteases. PLoS One (2011) 1.11
Psoriasis alters HDL composition and cholesterol efflux capacity. J Lipid Res (2012) 1.11
Prostaglandin E2 inhibits eosinophil trafficking through E-prostanoid 2 receptors. J Immunol (2008) 1.11
Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension. J Am Coll Cardiol (2006) 1.11
Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension. Respiration (2011) 1.10
Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. J Heart Lung Transplant (2011) 1.09
Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies. J Am Coll Cardiol (2006) 1.08
Prostacyclin and its analogues in the treatment of pulmonary hypertension. Pharmacol Ther (2004) 1.08
The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55. J Biol Chem (2012) 1.05
Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo. Circ Res (2009) 1.05
Role of store-operated calcium channels and calcium sensitization in normoxic contraction of the ductus arteriosus. Circulation (2006) 1.04
Myeloperoxidase-derived chlorinating species induce protein carbamylation through decomposition of thiocyanate and urea: novel pathways generating dysfunctional high-density lipoprotein. Antioxid Redox Signal (2012) 1.02
TGF-β directs trafficking of the epithelial sodium channel ENaC which has implications for ion and fluid transport in acute lung injury. Proc Natl Acad Sci U S A (2013) 1.01
Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations. Respir Res (2011) 1.01
Impaired Rho GTPase activation abrogates cell polarization and migration in macrophages with defective lipolysis. Cell Mol Life Sci (2011) 1.00
Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities. Chest (2008) 1.00
PGD2 metabolism in plasma: kinetics and relationship with bioactivity on DP1 and CRTH2 receptors. Biochem Pharmacol (2007) 0.99
Regulation of cerebral endothelial cell morphology by extracellular calcium. Phys Med Biol (2007) 0.98
Aging affects high-density lipoprotein composition and function. Biochim Biophys Acta (2013) 0.98
The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking. J Immunol (2007) 0.98
Inconsistent results of diagnostic tools hamper the differentiation between bee and vespid venom allergy. PLoS One (2011) 0.96
Role of the blood-brain barrier in the formation of brain metastases. Int J Mol Sci (2013) 0.96
Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine. Br J Pharmacol (2002) 0.96
The photochemical reaction cycle of proteorhodopsin at low pH. Biophys J (2003) 0.96
Blood flow vortices along the main pulmonary artery measured with MR imaging for diagnosis of pulmonary hypertension. Radiology (2014) 0.96
Cyanate is a novel inducer of endothelial icam-1 expression. Antioxid Redox Signal (2011) 0.96
Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension. Am J Respir Crit Care Med (2014) 0.96
A novel channelopathy in pulmonary arterial hypertension. N Engl J Med (2013) 0.95
Endothelin-1 inhibits background two-pore domain channel TASK-1 in primary human pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol (2009) 0.95
Changes induced by hyperosmotic mannitol in cerebral endothelial cells: an atomic force microscopic study. Eur Biophys J (2006) 0.94
A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function. J Pharmacol Exp Ther (2013) 0.93